Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $1.46, $0.16 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.54 billion.

GUIDANCE:

Encompass Health Corporation sees FY2026 EPS of $5.81-$6.10, versus the consensus of $5.82. Encompass Health Corporation sees FY2026 revenue of $6.365-6.465 billion, versus the consensus of $6.446 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.